Intermediate Monocytes

Intermediate monocytes are a distinct subset of human monocytes characterized by the following features:

1. Surface markers: They express high levels of CD14 and low levels of CD16 (CD14++CD16+) 6.
2. Proportion: They constitute a small percentage (2-11%) of total monocytes in circulation under normal conditions 3 5.
3. Antigen presentation: Intermediate monocytes express the highest levels of antigen presentation-related molecules, including HLA-DR, among monocyte subsets12.
4. Cytokine production: Upon stimulation, they can secrete both pro-inflammatory (TNF-α, IL-1β, IL-6, CCL3) and anti-inflammatory (IL-10) cytokines25.
5. Chemokine receptors: They express high levels of CCR5, which contributes to their susceptibility to HIV-1 infection 1 2.
6. Function: Intermediate monocytes are involved in antigen processing and presentation, transendothelial migration, and play a role in various inflammatory conditions 1.
7. Gene expression: They express 87% of genes and surface proteins at levels between classical and nonclassical monocytes, suggesting a transitional state 7.
8. Phagocytic ability: Intermediate monocytes show some phagocytic function, though less than classical monocytes 5.

Intermediate monocytes are considered a transitional subset between classical and non-classical monocytes, displaying characteristics of both populations58.

What role do intermediate monocytes play in chronic inflammatory diseases?

Intermediate monocytes (CD14++CD16+) play a complex role in chronic inflammatory diseases, acting as both pro-inflammatory mediators and immune regulators. Their involvement varies across conditions but consistently correlates with disease progression and severity. Below is a synthesis of their key roles:

1. Pro-Inflammatory Contributions

• Cytokine production:

Intermediate monocytes secrete high levels of pro-inflammatory cytokines (e.g., TNF-α, IL-1β, IL-6, CCL3) in response to chronic stimuli, sustaining inflammation in diseases like atherosclerosis, rheumatoid arthritis, and inflammatory bowel disease (IBD)134.

• Pathogen defense:

In chronic infections (e.g., HIV), their high CCR5 expression facilitates viral entry, contributing to viral persistence and immune activation13.

• Tissue damage:

In atherosclerosis, they infiltrate plaques, promote foam cell formation, and release reactive oxygen species (ROS), accelerating plaque instability24.

2. Immune Regulation and Resolution

• Anti-inflammatory mediators:

Paradoxically, intermediate monocytes also produce IL-10, which suppresses excessive inflammation and aids tissue repair36.

• Antigen presentation:

They express high levels of HLA-DR and costimulatory molecules (CD80/CD86), enabling T-cell activation and adaptive immune responses in autoimmune and metabolic diseases37.

• Phenotypic plasticity:

Intermediate monocytes can transition into reparative macrophages in response to IL-4/IL-10, supporting tissue healing in myocardial infarction or liver injury47.

3. Disease-Specific Roles

4. Biomarker Potential

• Elevated intermediate monocyte counts in blood correlate with:

• • Disease severity in atherosclerosis and IBD13.
  • Poor prognosis in heart failure and cancer46.
  • Increased fibrosis in chronic kidney disease7.

5. Therapeutic Implications

• Targeting cytokines: Blocking TNF-α or IL-6 signaling (e.g., biologics) may reduce their pro-inflammatory effects.
• CCR5 inhibition: Drugs like maraviroc could limit HIV reservoir formation 1 3.
• Reprogramming plasticity: Promoting their transition to reparative macrophages via IL-4/IL-10 pathways 4 7.

Key Challenges

• Dual roles: Their simultaneous pro- and anti-inflammatory functions complicate therapeutic targeting.
• Subset heterogeneity: Variability in surface markers and function across diseases demands context-specific strategies26.

HERBS

Several herbs have been shown to influence intermediate monocytes and monocyte function in general:

1. Panax notoginseng: Panax notoginseng saponins (PNS) inhibit monocyte adhesion to activated endothelium and reduce expression of adhesion molecules like ICAM-1 and VCAM-1 1.
2. Buddleja officinalis: The aqueous extract inhibits monocyte adhesion and reduces expression of adhesion molecules VCAM-1 and ICAM-1 1.
3. Salvia miltiorrhiza (Red sage): Extracts and compounds from this herb, including salvianolic acid B, reduce expression of adhesion molecules and inhibit monocyte adhesion1.
4. Curcuma longa (Turmeric): Bisacurone from turmeric inhibits expression of adhesion molecules and monocyte adhesion1.
5. Magnolia officinalis: Magnolol from this herb reduces monocyte adhesion and inflammatory signaling1.
6. Cranberry: Extracts rich in flavonoids, especially anthocyanins and flavonols like quercetin and myricetin, reduce inflammatory cytokine production (IL-6, TNF-α, IL-1β) in monocytes5.
7. Huang-Lian-Jie-Du decoction: This multi-herb formula containing Coptis chinensis, Scutellaria baicalensis, Phellodendron amurense, and Gardenia jasminoides affects monocyte subsets and myelopoiesis in inflammation models3.

While these herbs influence monocyte function, their specific effects on intermediate monocytes are not always clearly delineated in the research. The impact on intermediate monocytes may be inferred from overall effects on monocyte subsets and inflammatory processes.